Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 1842 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Assistant chef de produit dermatologie (Maladie de Verneuil) en stage Early Career (durée déterminée), Full time | Marketing | France | Paris Headquarter (PHARMA) | Jan 28, 2026 |
| Assistant chef de produit (maladie de Verneuil) en stage Early Career (durée déterminée), Full time | Marketing | France | Paris Headquarter (PHARMA) | Jan 28, 2026 |
| Tax Statutory Specialist Regular, Full time | Strategic Planning & BD&L | Mexico | INSURGENTES | Jan 28, 2026 |
| Financial Planning & Analysis Manager Regular, Full time | Finance | Egypt | New Cairo | Jan 28, 2026 |
| Associate Director, Therapeutic Area (Cardiovascular & Metabolism (CVM)), Enterprise Competitive Intelligence Regular, Full time | General Management | India | Hyderabad (Office) | Jan 28, 2026 |
| Associate Director, Strategic CI, Enterprise Competitive Intelligence Regular, Full time | General Management | India | Hyderabad (Office) | Jan 28, 2026 |
| Associate Director, Therapeutic Area (Oncology) , Enterprise Competitive Intelligence Regular, Full time | General Management | India | Hyderabad (Office) | Jan 28, 2026 |
| Global Process Owner – Manufacturing Execution, Serialization & Product Tracking Regular, Full time | Information Technology | India | Hyderabad (Office) | Jan 28, 2026 |
| Sales Representative Derma (w/m/d), Gebiet Steiermark/Kärnten Regular, Full time | Marketing | Austria | Vienna | Jan 28, 2026 |
| Engineer (Process) (m/f/d) Regular, Full time | Production / Manufacturing | Austria | Schaftenau | Jan 28, 2026 |
Adverse Event Reporting
We encourage using the following electronic reporting tool for reporting into the safety database directly: https://www.report.novartis.com/
If electronic reporting tool is not working – please use the following Generic mailbox: [email protected]
CISCO: +20 2 22861000: Press 3 for Adverse Event Reporting